Sofosbuvir/velpatasvir, is a fixed dose combination medication for the treatment of hepatitis C. It combines sofosbuvir and velpatasvir. It is more than 90% effective for hepatitis C genotypes one through six. It also works for hepatitis C in those who also have cirrhosis or HIV/AIDS.
Active Ingredients: Sofosbuvir + Velpatasvir
Strength: Sofosbuvir 400 mg + Velpatasvir 100 mg
Manufactured by Natco Pharma.
Dosage Form: Tablets
Retail Pack: 28 in a bottle
IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.
For procurement cost of Sofosbuvir and Velpatasvir tablets brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the Sofosbuvir and Velpatasvir tablets medicine cost price in India.
The order for Sofosbuvir and Velpatasvir tablets will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Velpanat (Sofosbuvir and Velpatasvir) tablets, for oral use
Generic Name: sofosbuvir and velpatasvir
For injection: 0.9 mg lyophilized powder in a single-dose vial for reconstitution and further dilution.
IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand Sofosbuvir and Velpatasvir tablets on prescription and Import License in Patient's Name only.
For overseas patients, Sofosbuvir and Velpatasvir tablets can be made available in Send your enquiry to find Sofosbuvir and Velpatasvir tablets in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.
GERD and the Elderly Patient: Clinical Considerations For More Details
Profile of sofosbuvir/velpatasvir/voxilaprevir in the treatment of hepatitis C For More Details
Sofosbuvir/Velpatasvir for HCV Treatment in Patients Undergoing Dialysis For More Details